Literature DB >> 434221

Effect of tetrodotoxin on action potentials of the conducting system in the dog heart.

E Coraboeuf, E Deroubaix, A Coulombe.   

Abstract

Tetrodotoxin (TTX) shortens Purkinje fiber action potential duration (APD) at concentrations (greater than or equal to 3.3 x 10(-8) M) lower than that at which the maximum rate of rise decreases (approximately 10(-6) M). The shortening effect of TTX occurs either at low or high driving rate and is much greater in Purkinje fibers than in bundle branch and muscle fibers. As a result, at a TTX concentration of 1.3 x 10(-6) M, the APD is no longer statistically different all along the conducting system, i.e., the gating mechanism described by Myerburg et al. (Circ. Res. 26: 361-378, 1970) is suppressed. It is concluded that this gating mechanism is attributable, at least in part, to the existence of a TTX-sensitive inward sodium current lengthening the plateau of the Purkinje fiber action potential. Our experimental results and reconstruction of Purkinje fiber action potentials suggest that this current, which is more sensitive to TTX than the normal rapid sodium current, flows through a background sodium conductance or/and a small proportion of sodium channels with no inactivation mechanism (or inactivation mechanism different from normal). The importance of this finding for the mechanism of action of antiarrhythmic drugs is pointed out.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 434221     DOI: 10.1152/ajpheart.1979.236.4.H561

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  79 in total

1.  Comparison of the sodium currents in normal Purkinje fibres and Purkinje fibres surviving infarction--a pharmacological study.

Authors:  A Bril; A A Kinnaird; R Y Man
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

2.  Pharmacology and Toxicology of Nav1.5-Class 1 anti-arrhythmic drugs.

Authors:  Dan M Roden
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

3.  Na channels that remain open throughout the cardiac action potential plateau.

Authors:  Y M Liu; L J DeFelice; M Mazzanti
Journal:  Biophys J       Date:  1992-09       Impact factor: 4.033

4.  Ionic mechanisms for electrical heterogeneity between rabbit Purkinje fiber and ventricular cells.

Authors:  Oleg V Aslanidi; Rakan N Sleiman; Mark R Boyett; Jules C Hancox; Henggui Zhang
Journal:  Biophys J       Date:  2010-06-02       Impact factor: 4.033

5.  Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic.

Authors:  Tao Yang; Thomas C Atack; Dina Myers Stroud; Wei Zhang; Lynn Hall; Dan M Roden
Journal:  Circ Res       Date:  2012-06-20       Impact factor: 17.367

6.  Expression pattern of neuronal and skeletal muscle voltage-gated Na+ channels in the developing mouse heart.

Authors:  Volker Haufe; Juan A Camacho; Robert Dumaine; Bernd Günther; Christian Bollensdorff; Gisela Segond von Banchet; Klaus Benndorf; Thomas Zimmer
Journal:  J Physiol       Date:  2005-03-03       Impact factor: 5.182

7.  Tetrodotoxin differentially blocks peak and steady-state sodium channel currents in early embryonic chick ventricular myocytes.

Authors:  I R Josephson; N Sperelakis
Journal:  Pflugers Arch       Date:  1989-07       Impact factor: 3.657

8.  Characterization of depolarization induced by palytoxin and grayanotoxin-I in isolated cardiac tissues from dogs and guinea pigs.

Authors:  K Ito; N Saruwatari; K Mitani; Y Enomoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-07       Impact factor: 3.000

9.  Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.

Authors:  Ruth Dixon; Sarah Job; Ruth Oliver; Debra Tompson; John G Wright; Kay Maltby; Ulrike Lorch; Jorg Taubel
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335

Review 10.  Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart.

Authors:  Albertas Undrovinas; Victor A Maltsev
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.